Kotra Industries (0002) Fundamentals 2026 — P/E 14.5x, Revenue Analysis | SniperIQ
Kotra Industries (0002) is a MY-listed Healthcare company in Drug Manufacturers - Specialty & Generic with a market capitalization of RM553M, trading at RM3.73 on the KLS. This SniperIQ fundamentals page covers Kotra Industries's valuation (P/E 14.5x, P/B 1.9x), profitability (net margin 17.0%), revenue (RM231M in FY2024), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Kotra Industries's market cap?
Kotra Industries (0002) has a market capitalization of approximately RM553M, trading at RM3.73 on the KLS. Market cap moves with the live share price.
What is Kotra Industries's P/E ratio?
Kotra Industries's trailing twelve-month P/E ratio is 14.5x, with a price-to-book (P/B) of 1.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Kotra Industries?
Kotra Industries runs a net profit margin of 17.0%, a gross margin of 81.4%, and an operating margin of 21.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Kotra Industries generate?
Kotra Industries reported revenue of RM231M for fiscal year 2024, with net income of RM42M and earnings per share (EPS) of 0.29. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Kotra Industries pay a dividend?
Kotra Industries offers a trailing dividend yield of about 5.9%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Kotra Industries financially healthy?
Kotra Industries carries a debt-to-equity ratio of 0.08x and a current ratio of 2.57x, with a market beta of -0.08. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Kotra Industries a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Kotra Industries (0002) the key facts are: market cap RM553M, P/E 14.5x, revenue RM231M, 52-week range 3.7-4.49. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Kotra Industries's full fundamentals live
Get Kotra Industries's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.